APTAMERS
APTAMERS are synthetic antibodies that has the potential to replace current animal-harvested antibodies for molecular diagnostics applications in human healthcare, animal breeding, agriculture and food safety
BIOGENES has taken the science of aptamers to another level by using bio-computational technique to design and optimise the binding between aptamers and target molecules in a 3D virtual environment – at least 20X faster and cheaper than conventional lab-based methods.
APTAMERS AS SYNTHETIC ANTIBODIES
vs
ANIMAL HARVESTED ANTIBODIES
DNA-BASED, MORE STABLE
PROTEIN-BASED, LESS STABLE
LAB-SYNTHESIZED TO PRECISE SPECS
VARIATIONS IN PRODUCTION BATCH
NO ANIMALS ARE INVOLVED
ETHICAL ISSUES ON ANIMAL USE*
LOW COST TO SYNTHESIZE DNA OLIGONUCLEOTIDES
HIGH COST IN PRODUCTION & COMPLIANCE
MAN-MADE HENCE PATENTABLE
COMPLICATED PATENTING CRITERIA
